Literature DB >> 1711630

Effects of R 56,865, a preventer of cellular calcium overload, on left ventricular diastolic properties during pacing-induced ischemia in dogs.

G Vandeplassche1, C Hermans, L Wouters, M Borgers.   

Abstract

The effects of R 56,865, a compound with unusual calcium antagonistic properties, on altered left ventricular (LV) diastolic properties were studied during pacing-induced ischemia in dogs with coronary stenosis. Severe coronary artery stenosis was produced on both the left anterior descending (LAD) and circumflex (Cx) coronary arteries in anesthetized beta-blocked dogs. The right atrium was paced at 200 beats/min for 3 min. In the post-pacing period and before drug intervention, the most characteristic observation was a significant increase in LV end-diastolic pressure (LVEDP) and in the time constant of (tau) LV pressure decrease; after return of LV hemodynamics to baseline values (15 min), R 56,865 (0.16 mg.kg-1) or solvent (control) was injected and four subsequent pacing runs were performed at 30-min intervals. In the postpacing period of these four subsequent runs, there was a steep increase in LVEDP and tau-values while HR returned more slowly to baseline values. After R 56,865 infusion, the increase in LVEDP and tau-values was significantly lower than in the pretreatment run and all LVEDP values were significantly lower than in the control group. We conclude that R 56,865 effectively attenuates ischemia-induced changes in LV diastolic stiffness.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1711630     DOI: 10.1097/00005344-199104000-00015

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  2 in total

1.  The negative inotropic and chronotropic effects of intravenous R 56865 during percutaneous transluminal coronary angioplasty.

Authors:  A J Pijl; H B Van Wezel; J J Koolen; J J Piek; K Koch; A Swaan; G K David; C A Visser; P A Van Zwieten
Journal:  Br J Clin Pharmacol       Date:  1995-05       Impact factor: 4.335

2.  R56865 is antifibrillatory in reperfused ischemic guinea-pig hearts, even when given only during reperfusion.

Authors:  E Scheufler; A Mozes; I Guttmann; B Wilffert
Journal:  Cardiovasc Drugs Ther       Date:  1995-08       Impact factor: 3.727

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.